Original Research

Prevention is better than cure – the art of avoiding non-adherence to antiretroviral treatment

Leith Kwaan, Gurpreet Kindra, Lulama Mdutyana, Anna Coutsoudis
Southern African Journal of HIV Medicine | Vol 11, No 2 | a223 | DOI: https://doi.org/10.4102/sajhivmed.v11i2.223 | © 2010 Leith Kwaan, Gurpreet Kindra, Lulama Mdutyana, Anna Coutsoudis | This work is licensed under CC Attribution 4.0
Submitted: 15 December 2010 | Published: 04 November 2010

About the author(s)

Leith Kwaan, Department of Paediatrics and Child Health, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa
Gurpreet Kindra, Department of Paediatrics and Child Health, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa
Lulama Mdutyana, Department of Paediatrics and Child Health, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa
Anna Coutsoudis, Department of Paediatrics and Child Health, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa

Full Text:

PDF (129KB)

Abstract

The much-used phrase ‘prevention is better than cure’ is applicable to many circumstances, including human immunodeficiency virus (HIV) infection. In recent years suggestions have been made for a move towards treatment strategies that emphasise prevention of foreseeable adherence problems on a patient-by-patient basis, through focused patient preparation before commencing antiretroviral therapy (ART). This is well elucidated in a statement made in 2004 by Coetzee et al.:1 ‘As it is difficult to ascertain robust predictors of adherence, there has been a move to concentrate on patient preparation before the initiation of ART rather than the use of non-clinical predictors of adherence or selection criteria. A paradigm focused on preparation rather than selection is better suited to the aggressive targets for the scaling up of ART in countries with large epidemics (such as in South Africa), where the view of ART as a very expensive rationed intervention is rapidly changing.’

Keywords

No related keywords in the metadata.

Metrics

Total abstract views: 3907
Total article views: 2568

 

Crossref Citations

1. Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study
Landon Myer, Rose Zulliger, Linda-Gail Bekker, Elaine Abrams
BMC Pregnancy and Childbirth  vol: 12  issue: 1  year: 2012  
doi: 10.1186/1471-2393-12-94

2. PIMATM point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa
Mandisa Skhosana, Shabashini Reddy, Tarylee Reddy, Siphelele Ntoyanto, Elizabeth Spooner, Gita Ramjee, Noluthando Ngomane, Anna Coutsoudis, Photini Kiepiela
Southern African Journal of HIV Medicine  vol: 17  issue: 1  year: 2016  
doi: 10.4102/sajhivmed.v17i1.444

3. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa
Landon Myer, Rose Zulliger, Samantha Black, David Pienaar, Linda-Gail Bekker
AIDS Care  vol: 24  issue: 8  first page: 986  year: 2012  
doi: 10.1080/09540121.2012.668173

4. Diversity of patient preparation activities before initiation of antiretroviral therapy in Cape Town, South Africa
Landon Myer, Rose Zulliger, David Pienaar
Tropical Medicine & International Health  vol: 17  issue: 8  first page: 972  year: 2012  
doi: 10.1111/j.1365-3156.2012.03033.x

5. The Public Health Impact of Foreign Aid Withdrawal by the United States Government and Its Implications for ARVs, Preexposure, and Postexposure Prophylaxis Medications in South Africa and Nigeria
Samuel Chima Ugbaja, Boitumelo Setlhare, Peterson Makinde Atiba, Hezekiel M. Kumalo, Mlungisi Ngcobo, Nceba Gqaleni
World  vol: 6  issue: 2  first page: 74  year: 2025  
doi: 10.3390/world6020074